These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37087097)

  • 1. Double-Blind, Placebo-Controlled Study of E-B-FAHF-2 in Combination With Omalizumab-Facilitated Multiallergen Oral Immunotherapy.
    Wang J; Wood RA; Raymond S; Suárez-Fariñas M; Yang N; Sicherer SH; Sampson HA; Li XM
    J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2208-2216.e1. PubMed ID: 37087097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
    Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
    Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.
    Wood RA; Kim JS; Lindblad R; Nadeau K; Henning AK; Dawson P; Plaut M; Sampson HA
    J Allergy Clin Immunol; 2016 Apr; 137(4):1103-1110.e11. PubMed ID: 26581915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009014. PubMed ID: 22972130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab.
    Yee CSK; Albuhairi S; Noh E; El-Khoury K; Rezaei S; Abdel-Gadir A; Umetsu DT; Burke-Roberts E; LeBovidge J; Schneider L; Rachid R
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):451-461.e7. PubMed ID: 30267889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
    Blumchen K; Trendelenburg V; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Holzhauser T; Roeder M; Rosenfeld L; Hartmann O; Niggemann B; Beyer K
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):479-491.e10. PubMed ID: 30423449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.
    Narisety SD; Frischmeyer-Guerrerio PA; Keet CA; Gorelik M; Schroeder J; Hamilton RG; Wood RA
    J Allergy Clin Immunol; 2015 May; 135(5):1275-82.e1-6. PubMed ID: 25528358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued
    Andorf S; Purington N; Kumar D; Long A; O'Laughlin KL; Sicherer S; Sampson H; Cianferoni A; Whitehorn TB; Petroni D; Makhija M; Robison RG; Lierl M; Logsdon S; Desai M; Galli SJ; Rael E; Assa'ad A; Chinthrajah S; Pongracic J; Spergel JM; Tam J; Tilles S; Wang J; Nadeau K
    EClinicalMedicine; 2019 Jan; 7():27-38. PubMed ID: 31193674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peanut Oral Immunotherapy With or Without H
    Chu DK; Freitag T; Marrin A; Walker TD; Avilla E; Freitag A; Spill P; Foster GA; Thabane L; Jordana M; Waserman S
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2386-2394. PubMed ID: 35643280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy.
    Nowak-Węgrzyn A; Wood RA; Nadeau KC; Pongracic JA; Henning AK; Lindblad RW; Beyer K; Sampson HA
    J Allergy Clin Immunol; 2019 Feb; 143(2):651-661.e9. PubMed ID: 30389226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy.
    Wang J; Jones SM; Pongracic JA; Song Y; Yang N; Sicherer SH; Makhija MM; Robison RG; Moshier E; Godbold J; Sampson HA; Li XM
    J Allergy Clin Immunol; 2015 Oct; 136(4):962-970.e1. PubMed ID: 26044855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab facilitates rapid oral desensitization for peanut allergy.
    MacGinnitie AJ; Rachid R; Gragg H; Little SV; Lakin P; Cianferoni A; Heimall J; Makhija M; Robison R; Chinthrajah RS; Lee J; Lebovidge J; Dominguez T; Rooney C; Lewis MO; Koss J; Burke-Roberts E; Chin K; Logvinenko T; Pongracic JA; Umetsu DT; Spergel J; Nadeau KC; Schneider LC
    J Allergy Clin Immunol; 2017 Mar; 139(3):873-881.e8. PubMed ID: 27609658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy.
    Frischmeyer-Guerrerio PA; Masilamani M; Gu W; Brittain E; Wood R; Kim J; Nadeau K; Jarvinen KM; Grishin A; Lindblad R; Sampson HA
    J Allergy Clin Immunol; 2017 Oct; 140(4):1043-1053.e8. PubMed ID: 28414061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
    Vickery BP; Scurlock AM; Kulis M; Steele PH; Kamilaris J; Berglund JP; Burk C; Hiegel A; Carlisle S; Christie L; Perry TT; Pesek RD; Sheikh S; Virkud Y; Smith PB; Shamji MH; Durham SR; Jones SM; Burks AW
    J Allergy Clin Immunol; 2014 Feb; 133(2):468-75. PubMed ID: 24361082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
    Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
    BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.
    Varshney P; Jones SM; Scurlock AM; Perry TT; Kemper A; Steele P; Hiegel A; Kamilaris J; Carlisle S; Yue X; Kulis M; Pons L; Vickery B; Burks AW
    J Allergy Clin Immunol; 2011 Mar; 127(3):654-60. PubMed ID: 21377034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.
    Schneider LC; Rachid R; LeBovidge J; Blood E; Mittal M; Umetsu DT
    J Allergy Clin Immunol; 2013 Dec; 132(6):1368-74. PubMed ID: 24176117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
    O'B Hourihane J; Beyer K; Abbas A; Fernández-Rivas M; Turner PJ; Blumchen K; Nilsson C; Ibáñez MD; Deschildre A; Muraro A; Sharma V; Erlewyn-Lajeunesse M; Zubeldia JM; De Blay F; Sauvage CD; Byrne A; Chapman J; Boralevi F; DunnGalvin A; O'Neill C; Norval D; Vereda A; Skeel B; Adelman DC; du Toit G
    Lancet Child Adolesc Health; 2020 Oct; 4(10):728-739. PubMed ID: 32702315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal.
    Marrs T; Flohr C; Perkin MR
    Br J Dermatol; 2015 Nov; 173(5):1125-9. PubMed ID: 26769642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial.
    Andorf S; Purington N; Block WM; Long AJ; Tupa D; Brittain E; Rudman Spergel A; Desai M; Galli SJ; Nadeau KC; Chinthrajah RS
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):85-94. PubMed ID: 29242014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.